Race-neutral pulmonary function testing, now recommended by ATS and implemented at Boston Medical Center, has had a long road ...

The FDA has approved nerandomilast (Jascayd; Boehringer Ingelheim) for the treatment of adults with idiopathic pulmonary ...

Interstitial Lung Disease (ILD): In the PHAROS trial, 1 patient (1%) receiving MEKTOVI with BRAFTOVI developed pneumonitis. Assess new or progressive unexplained pulmonary symptoms or findings for ...

He went to a nearby emergency clinic, where doctors told him that he was probably constipated. They gave him some laxatives ...

With three-quarters of a century dedicated to advancing cardiovascular science and improving patient care, the ESC ...

The study, presented at the European Respiratory Society Congress in Amsterdam, showed those who used wood stoves lost lung capacity more quickly than non-users – even though they tended to be ...

Introduction Stroke is the second leading cause of death and disability creating a huge economic burden annually. Robot-assisted training (RT) is a promising therapy in stroke rehabilitation, but for ...

Suspicion for malignancies that are a part of genetic syndromes, such as neurofibromatosis type I (NF-1), should prompt genetic testing ... tumor behind or sacrificing function in order to achieve ...

The complete blood count routine test provides a snapshot of your body's blood production and immunity. The test measures a variety of components in your blood, including red blood cells, white blood ...

Real-world use of antifibrotic therapy is associated with greater estimated survival in pulmonary fibrosis interstitial lung disease (PF-ILD).

The biologics omalizumab, mepolizumab, benralizumab, and dupilumab have similar effectiveness in improving lung function in severe asthma.